INCFinder

GenBank ID	AP026734.1
Plasmid name	pNUITM-VS2_2 DMA
Classification	C2
Length	152 182 bp
GC content	53%
Organism	Shewanella xiamenensis NUITM-VS2
Curation	Manually annotated

The site of I1 insertion is missing.

Gene name	Length	Location	Length of alignment	Identity (%)	Coverage (%)
repA	1101	1 - 1101 (+)	1101	100	100
ORF1847	5544	56971 - 62514 (+)	5544	100	100
I2	462	38897 - 39358 (+)	462	100	100
RHS2	4263	103301 - 107563 (+)	4263	100	100
AriB	640	24533 - 25172 (+)	640	100	24
AriB	640	19925 - 20564 (+)	640	100	24

Type match	Model name	Model type	Location	E-value	Identity
Perfect	Tet(X4)	protein homolog model	21948 - 23105(+)	0	100 %
tetracycline inactivation enzyme AMR Gene Family Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds. tigecycline Antibiotic Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome. tetracycline Antibiotic Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome. glycylcycline Drug Class Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA. tetracycline antibiotic Drug Class These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes. antibiotic inactivation Resistance Mechanism Enzymatic inactivation of antibiotic to confer drug resistance.